Gut homeostasis involves interrelated biological networks that include the immune system, specialized cells of the epithelium, such as Paneth and goblet cells, as well as triggers derived from the microbiota. Disruption of these homeostatic interactions may lead to the pathogenesis of inflammatory bowel diseases (IBD). To develop more targeted and individual treatments in Crohn's disease and ulcerative colitis, it becomes more and more important to link key mechanisms of the disease pathogenesis to distinct IBD subsets. For the first time, our laboratory demonstrated a causal role of the microbiota for the development of Crohn's disease (CD)-like ileitis, supporting the hypothesis that a non-infectious, dysbiotic microbial ecosystem harbors aggressive traits relevant for the induction of chronic inflammation in the disease-susceptible host (i.e. TNF DARE mouse model). Despite a growing body of evidence claiming a primary role for Paneth cells in the pathogenesis of ileal CD, we showed in the TNF DARE mouse model that Paneth cell failure or exhaustion is a secondary event to inflammation. Therefore, additional mechanisms may act synergistically to initialize the development of CD-like pathology. Hereby, we propose a novel hypothesis suggesting that individual development of dysbiotic communities is based on stochastic injury and focal inflammation of the epithelial lining that propagate radially, finally leading to an aggressive microbial milieu.
Dysbiotic microbiota induces transmissible CD-like ileitis in susceptible host
Our laboratory recently demonstrated that germ-free (GF) TNF DARE mice do not develop CD-like ileitis, supporting the initial hypothesis that bacterial triggers are essential tassels of disease pathogenesis. 1 Of high relevance, only specific (dysbiotic) bacterial communities (so-called responder, "R," or aggressive microbiota) are associated to a disease phenotype in these mice, capable to transmit disease once transferred into a GF susceptible host (TNF DARE mice). 1 In contrast, microbiota derived from wild-type (WT) as well as from healthy but disease susceptible hosts (so-called non-responder, "NR," or non-aggressive microbiota) is unable to trigger disease once transferred into GF TNF DARE mice. 1 These results provide functional evidence that dynamic alterations of the microbial ecosystem (dysbiosis) cause transmissible disease in the susceptible host. The use of 16S rRNA gene sequencing demonstrated a clear shift in bacterial community structure of R and NR mice at the age of 8 weeks, culminating at 18 weeks of age and correlating with tissue pathology 1 ( Fig. 1A and B) . In contrast, in early life, during the post weaning phase, R and NR microbiota clustered together, showing no signs of dysbiosis or inflammation (Fig. 1C) . This piece of evidence suggests that shifts in microbiota composition develop with gradually increasing inflammation and occur after maternal separation. 1 Therefore, the investigation in our laboratory revolves around unraveling the events that trigger changes in the microbiota toward the assembling of dysbiotic bacterial communities. This aspect should be studied by kinetics analysis of the microbiota in different organ systems and of the innate and adaptive immune response (e.g. granulocytes and effector T cells and/or antigen specific T cells) to determine whether the selection of dysbiotic microbiota is based on innate tissue activation or on antigen recognition.
Gut epithelial stochastic injuries generate focal inflammation leading to a dysbiotic microbial ecosystem: A provoking hypothesis It is very challenging to unravel the mechanisms by which inflammation drives bacterial taxa selection and molds microbiota into a disease-conditioning community. Since cage and litter effects were excluded, our current hypothesis rests on the assumption that morphological modifications of the epithelial interface, previously described as focal lesions, 2 occur stochastically in the gut and may alter the local milieu affecting bacterial abundance and fitness. 3, 4 Actually, while a healthy host is able to seal off the damage, the susceptible individual lacks the ability to restore mucosal integrity, resulting in an altered gut milieu leading to barrier dysfunction and expansion of focal lesions [2] [3] [4] ( Fig. 2A and  B) . Based on the recently published evidence related to inflammation-mediated changes of bacterial gene expression, we believe that an inflammatory setting generated around focal lesions may up-regulate virulence-associated bacterial genes. 5 We speculate that, in such an altered environment, bacterial taxa with aggressive or virulent features may find an ideal niche to propagate and to exert a negative selection on other beneficial commensals. Recent unpublished evidence reports that focal lesion occurrence is mouse strain dependent and that they are enriched in a selected bacterial community. 4 Therefore, we suggest the hypothesis that focal lesions may fuel changes in the host microbiota, reprogramming its disease-conditioning nature, and that the transfer of such pre-selected community may results in dysbiosis-associated transmissible disease in a susceptible host (TNF DARE mice).
1-4
Paneth cell dysfunction does not precede inflammation and ileal pathology in TNF DARE mouse model of CD-like ileitis Abnormalities in Paneth cells structure and function have been increasingly recognized in IBD, and a growing body of evidence on Paneth cell lineage ablation supports their role in inflammation. 7 Emerging data from genome-wide association studies (GWAS) in human cohorts also suggest that Paneth cells may play a critical role in the disease pathogenesis of IBD, specifically targeting CD. Key genes involved in Paneth cell function include XBP1, ORMDL3, NOD2, ATG16L1 and IRGM. 6, [8] [9] [10] [11] The genetic deletion of Nod2 gene in mice results in Paneth cell dysfunction with a substantial reduction in the expression of a specific class of antimicrobial peptides (i.e., a-defensins) in the crypts of these mice, mirroring Paneth cell malfunction found in CD patients carrying the NOD2 mutation. 12, 13 Mice bearing mutations in genes associated with autophagy (ATG16L1 and IRGM genes) or in a gene involved in the endoplasmic reticulum stress response (XBP1) develop exacerbated intestinal inflammation and abnormalities in Paneth cell morphology and function, including diminished antimicrobial peptide secretion. 11, [14] [15] [16] It is necessary to acknowledge that not all studies support the finding that the deficiency of a-defensins expression is a predisposing factor for CD. For instance, Simms and coworkers showed that reduced levels of a-defensins are seen in CD, however this reduction is correlated with inflammation rather than with the NOD2 genotype of patients. 17 This observation is in agreement with our findings, demonstrating that Paneth cell dysfunction is the consequence of inflammation rather than its cause. 1 Of note, our transfer experiments of microbiota from R mice into GF TNF DARE mice provided clear evidence that transcriptional activation of TNF and ileal pathology preceded Paneth cell dysfunction 1 (Fig. 3) . Failure of Paneth cell functionality, determined by the reduced protein expression of lysozyme and cryptdin-2 using immunofluorescence analysis, was an event subsequent to inflammation, and that was not caused by Paneth cell apoptosis in TNF DARE mice. 1 One tempting hypothesis is that the generation of reacting oxygen species (ROS) in response to inflammatory processes may lead to the functional exhaustion of Paneth cells. 18 This is speculative and requires validation in TNF DARE mice. It seems plausible to assume that the various IBD-related mouse models represent a distinct subset of patients and thus one subset of the disease pathogenesis.
Conclusions and key open questions
Compositional and functional shifts in the intestinal microbial ecosystem are considered to represent key mechanisms in the pathogenesis of IBD. Highthroughput sequencing analysis of microbial communities from patients with Crohn's disease and ulcerative colitis identified risk patterns associated with these distinct IBD phenotypes, however functional evidence for the existence of disease-conditioning ecosystems The gut microbiota is constantly exposed to intrinsic (i.e., host genetics) and environmental factors (i.e., diet, smoking, antibiotics) that may induce non-permanent alteration in the bacterial community structure, leading to an homeostatic "alternative state." 6 However, the resilience of the gut microbiota may be lost in some pathologies, such as IBD, resulting in dysbiosis. (B) Our current hypothesis focuses on the formation in the epithelial lining of focal lesions, which cannot be sealed off in the genetic susceptible host. 3 We speculate that the environmental milieu established in these lesions promotes the selection of specific bacterial taxa with aggressive and virulent features, which fuel inflammatory processes resulting in tissue pathology. Intact villi in GF mice (12 weeks old) are indicated by white arrows, while eroded villi are highlighted by orange arrows. (dysbiosis) or the selection of single taxa (pathobionts) as underlying cause of chronic inflammation is still lacking. 6 Until now, mechanistic studies about the role of bacteria in the pathogenesis of CD with predominant ileal inflammation were hampered by the lack of adequate GF mouse models. GF animal models susceptible to inflammatory pathologies are excellent tools to study the causal role of microbial ecosystems in disease initiation. However, when using a GF mouse model approach, it is essential to investigate bacterial colonization efficiency, which may be affected by several factors. In fact, a specific time window is required to develop a stable microbiota composition and a normal mucus system. [19] [20] [21] Moreover, host mechanisms are important for the selection of a host-specific microbiota, e.g., host specificity, 22 host immune system maturation, 23 host gut selective pressure 24 and host glycan repertoire. 19, 25 The use of antibiotics in place of GF mouse models should be carefully examined owing to the specific effects of antibiotics on different bacterial taxa, possibly resulting in selection of aggressive microbiota, and on the host epithelium, such as mucus thickening processes. 19 For the first time, our laboratory showed that inflammation-associated changes in the microbiota caused transmissible disease in the genetically susceptible host (TNF DARE mice) but not in WT recipients. 1 Schaubeck and coworkers demonstrated that microbial communities, although developed under the same experimental conditions, may undergo progressive changes in their structures, leading to a more aggressive phenotype over time. 1 The current goal is to identify the trigger that drives microbiota modification from neutral to aggressive nature. A growing body of evidence reports that several IBD susceptibility genes are associated with Paneth cell dysfunction. Nevertheless, in the TNF DARE mouse model, Paneth cell loss was a secondary event to inflammation and tissue pathology. 1 Given that TNF reduces epithelial barrier function by promoting sharp increases in tight junction permeability, 26 it can be speculated that specific levels of TNF, such as those detected in lowR and R mice, are necessary to induce intestinal epithelial cells impairment, resulting in Paneth cell failure. To explain different grade of disease onset in our TNF DARE mouse model, we propose that stochastic injuries in the gut mucosa generate focal inflammation leading to a dysbiotic microbial ecosystem with an individual selection of bacteria. This may explain the so far unmet effort to identify a unified microbial profile or single bacterial taxa responsible for the pathogenesis of IBD. Inflamed tissue areas in the gut are often enriched or depleted of selective bacterial taxa (e.g., Proteobacteria or Clostridia), most likely highlighting the fact that those bacteria quickly adapt to an altered milieu rather than being responsible for disease development. Despite these findings, 1 we still have no understanding about the characteristic features of diseaseconditioning (dysbiotic) microbial communities. Therefore, our long-term aim is to better identify the functional plasticity of complex microbial ecosystems toward changes in the intestinal milieu, such as those triggered by focal injuries and inflammation. Mechanistically, the most important question is centered on a systematic understanding of microbe-host interactions leading to the onset of disease. Most importantly, will it be possible to predict disease onset or relapse based on individual microbiota composition and function? Although fecal material transplantation (FMT) is a quite promising option for IBD treatment, its therapeutic efficacy is still poor, supporting the hypothesis that the selection patient-specific donor microbiota is not rationalized. 27, 28 In conclusion, a systematic investigation of the molecular mechanisms underpinning the development of dysbiosis in the context of stochastically appearing focal injuries in the gut mucosa is likely to offer new insights into the pathophysiology of chronic inflammatory diseases.
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